Search
Generic filters
Search in excerpt

An ETF for every investor.

CASH

Horizons High Interest Savings ETF

Price
$50.16
$0.03
0.05%
NAV
$50.1440
$0.0058
0.01%

Benchmark

Fixed Income

Fact Sheet
Learn more about CASH

QQCC

Horizons NASDAQ-100 Covered Call ETF

Price
$9.78
$0.04
0.41%
NAV
$9.7762
$-0.0039
-0.04%

Active

Covered Call

Fact Sheet
Learn more about QQCC

HRAA

Horizons ReSolve Adaptive Asset Allocation ETF

Price
$11.22
$0.02
0.18%
NAV
$11.2056
$-0.0234
-0.21%

Active

Corporate Class – Alternative

Fact Sheet
Learn more about HRAA
Explore All Products
Search
Generic filters
Search in excerpt

This Webinar Covers:

On January 27, 2021, Horizons ETFs launched the Horizons Psychedelic Stock Index ETF (PSYK), which offers investors unique exposure to the emerging North American psychedelics industry.

On February 18, 2021, we hosted a webinar that saw more than 1,000 investors join us to learn about the potential of the psychedelics sector and our investing insights.

You can now watch our webinar replay with Steve Hawkins, CEO of Horizons ETFs, and Mark Noble, Executive Vice-President of ETF Strategy, uncover the potential investment opportunities presented by psychedelic therapeutics and research being pursued by Canadian and American life sciences companies, including some of the world’s largest pharmaceutical names.